{"altmetric_id":6985628,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":31},"twitter":{"unique_users_count":15,"unique_users":["NeurologyToday","msanchezdelrio","dlh75","GMSA_CME","PeytonNoelle55","HYHUTriangle","Kunstery","KZneuron","deep_wreck","L2583","lgeneral15","C_OrejaGuevara","mikel_franco","MSMmeeting","POSTECTRIMS"],"posts_count":29},"facebook":{"unique_users_count":1,"unique_users":["193133835711"],"posts_count":2}},"selected_quotes":["#AANAM2016: Retinal thickness helps indicate #multiplesclerosis progression","Retinal Thickness Predicts MS Worsening Two to Five Years Out, Offering Useful Clinical and Trial Markers","Retinal Thickness Predicts MS Worsening Two to Five Years Out, Useful Clinical and Trial Markers","News from the AAN Annual Meeting: Retinal Thickness Predicts... : Neurology Today"],"citation":{"altmetric_jid":"4f6fa62f3cf058f6100082a1","authors":["Hurley, Dan"],"doi":"10.1097\/01.nt.0000483051.48360.4e","endpage":"9","first_seen_on":"2016-04-27T12:01:50+00:00","issns":["1533-7006"],"issue":"8","journal":"Neurology Today","last_mentioned_on":1484336177,"links":["http:\/\/journals.lww.com\/neurotodayonline\/Fulltext\/2016\/04210\/News_from_the_AAN_Annual_Meeting__Retinal.4.aspx","http:\/\/journals.lww.com\/neurotodayonline\/Pages\/articleviewer.aspx?mobile=0&year=2016&issue=04210&article=00004&type=Fulltext","http:\/\/journals.lww.com\/neurotodayonline\/Pages\/articleviewer.aspx?year=2016&issue=04210&article=00004&type=Fulltext"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/neurotodayonline\/2016\/04210\/News_from_the_AAN_Annual_Meeting__Retinal.4.pdf","pubdate":"2016-04-21T00:00:00+00:00","startpage":"7","title":"News from the AAN Annual Meeting","type":"article","uri":"http:\/\/journals.lww.com\/neurotodayonline\/Fulltext\/2016\/04210\/News_from_the_AAN_Annual_Meeting__Retinal.4.aspx","volume":"16"},"altmetric_score":{"score":9.7,"score_history":{"1y":0.75,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":9.7},"context_for_score":{"all":{"total_number_of_other_articles":8246634,"mean":6.9687008317149,"rank":889321,"this_scored_higher_than_pct":89,"this_scored_higher_than":7355818,"rank_type":"exact","sample_size":8246634,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":271586,"mean":11.551754441519,"rank":42288,"this_scored_higher_than_pct":84,"this_scored_higher_than":229213,"rank_type":"exact","sample_size":271586,"percentile":84},"this_journal":{"total_number_of_other_articles":1367,"mean":6.3137920937042,"rank":273,"this_scored_higher_than_pct":79,"this_scored_higher_than":1093,"rank_type":"exact","sample_size":1367,"percentile":79},"similar_age_this_journal_3m":{"total_number_of_other_articles":68,"mean":6.1753731343284,"rank":13,"this_scored_higher_than_pct":80,"this_scored_higher_than":55,"rank_type":"exact","sample_size":68,"percentile":80}}},"demographics":{"poster_types":{"member_of_the_public":13,"researcher":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":13,"Scientists":1,"Practitioners (doctors, other healthcare professionals)":1}}},"geo":{"twitter":{"US":1,"ES":4,"NL":1,"CA":1,"AT":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/NeurologyToday\/statuses\/725293747458740224","license":"gnip","citation_ids":[6985628],"posted_on":"2016-04-27T12:01:19+00:00","author":{"name":"Neurology Today","url":"http:\/\/www.neurotodayonline.com","image":"https:\/\/pbs.twimg.com\/profile_images\/474220858295078914\/vUs3O0B__normal.png","description":"The official news source of the American Academy of Neurology, published by Wolters Kluwer.","id_on_source":"NeurologyToday","tweeter_id":"21938868","geo":{"lt":44.97997,"ln":-93.26384,"country":"US"},"followers":31049},"tweet_id":"725293747458740224"},{"url":"http:\/\/twitter.com\/msanchezdelrio\/statuses\/725298922227404800","license":"gnip","rt":["NeurologyToday"],"citation_ids":[6985628],"posted_on":"2016-04-27T12:21:53+00:00","author":{"name":"Dra. Sanchez del Rio","url":"http:\/\/dra-sanchez-del-rio.com","image":"https:\/\/pbs.twimg.com\/profile_images\/471400607656730624\/Ok2rE3FJ_normal.jpeg","description":"#Neurologo especializado en #cefaleas, #neuralgia, #migra\u00f1a","id_on_source":"msanchezdelrio","tweeter_id":"1225703623","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":391},"tweet_id":"725298922227404800"},{"url":"http:\/\/twitter.com\/dlh75\/statuses\/725302694211117057","license":"gnip","rt":["NeurologyToday"],"citation_ids":[6985628],"posted_on":"2016-04-27T12:36:52+00:00","author":{"name":"Donna Hopkins","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"dlh75","tweeter_id":"420319071","geo":{"lt":null,"ln":null},"followers":24},"tweet_id":"725302694211117057"},{"url":"http:\/\/twitter.com\/GMSA_CME\/statuses\/725334763863678976","license":"gnip","rt":["NeurologyToday"],"citation_ids":[6985628],"posted_on":"2016-04-27T14:44:18+00:00","author":{"name":"Global MS Academy","url":"https:\/\/www.globalmultiplesclerosisacademy.org\/en\/","image":"https:\/\/pbs.twimg.com\/profile_images\/530003741538127872\/SqHebs3V_normal.jpeg","description":"The Global Multiple Sclerosis Academy (GMSA) is an educational program for physicians and other healthcare professionals involved with multiple sclerosis.","id_on_source":"GMSA_CME","tweeter_id":"2861628225","geo":{"lt":null,"ln":null},"followers":153},"tweet_id":"725334763863678976"},{"url":"http:\/\/twitter.com\/PeytonNoelle55\/statuses\/725368677768548352","license":"gnip","rt":["NeurologyToday"],"citation_ids":[6985628],"posted_on":"2016-04-27T16:59:04+00:00","author":{"name":"Peyton Puckett","image":"https:\/\/pbs.twimg.com\/profile_images\/825208055591796738\/Hlo_I4IC_normal.jpg","id_on_source":"PeytonNoelle55","tweeter_id":"2536072291","geo":{"lt":null,"ln":null},"followers":84},"tweet_id":"725368677768548352"},{"url":"http:\/\/twitter.com\/HYHUTriangle\/statuses\/725385301326180352","license":"gnip","rt":["NeurologyToday"],"citation_ids":[6985628],"posted_on":"2016-04-27T18:05:07+00:00","author":{"name":"Hold Your Head Up \ud83d\udc8e","image":"https:\/\/pbs.twimg.com\/profile_images\/2205910919\/177_normal.jpeg","description":"2x BrainTumorSurvivor \ud83e\udde0Meningioma\u2600Glomus Jugulare\/Cochlear\/Epilepsy\u2600Founder\ud83d\udc69\ud83c\udffe\u200d\ud83d\udcbb  Hold Your Head Up NonProfit\u2600 StrongFaithinGod\u2600Making A Difference in the World\u2600","id_on_source":"HYHUTriangle","tweeter_id":"122739382","geo":{"lt":null,"ln":null},"followers":6520},"tweet_id":"725385301326180352"},{"url":"http:\/\/twitter.com\/Kunstery\/statuses\/725736674874023937","license":"gnip","rt":["NeurologyToday"],"citation_ids":[6985628],"posted_on":"2016-04-28T17:21:21+00:00","author":{"name":"Kunstery","url":"http:\/\/www.kunstery.gallery","image":"https:\/\/pbs.twimg.com\/profile_images\/898910137284427778\/bqTQBZrU_normal.jpg","description":"KUNSTERY:  ART IS LIVING  ~ #metal #brba #BetterCallSaul #art #ms #NotDeadYet #animalrights  #kunst #health #humanrights #onzin #frustration #neuroscience #hope","id_on_source":"Kunstery","tweeter_id":"294856612","geo":{"lt":52.5,"ln":5.75,"country":"NL"},"followers":373},"tweet_id":"725736674874023937"},{"url":"http:\/\/twitter.com\/KZneuron\/statuses\/725796443944939520","license":"gnip","citation_ids":[6985628],"posted_on":"2016-04-28T21:18:51+00:00","author":{"name":"KENZOU","image":"https:\/\/pbs.twimg.com\/profile_images\/1118336447\/KZneuron_normal.jpg","description":"\u65e5\u672c\u3067\u4e00\u756a\u306f\u3057\u3063\u3053\u306b\u8fd1\u3044\u3068\u3053\u308d\u3067\u795e\u7d4c\u5185\u79d1\u3092\u3084\u3063\u3066\u307e\u3059\u3002\u52c9\u5f37\u3057\u306a\u304d\u3083\u3002(\u5f53\u756a\u3058\u3083\u7121\u3044\u65e5\u306f\u8d85\u30c9\u4e0b\u624bPCgamer)","id_on_source":"KZneuron","tweeter_id":"186621157","geo":{"lt":null,"ln":null},"followers":253},"tweet_id":"725796443944939520"},{"url":"http:\/\/twitter.com\/deep_wreck\/statuses\/725807784743161856","license":"gnip","rt":["KZneuron"],"citation_ids":[6985628],"posted_on":"2016-04-28T22:03:55+00:00","author":{"name":"\u4e59\u3042\u308a\u3043@\u30ec\u30d9\u30ea\u30f3\u30b0","image":"https:\/\/pbs.twimg.com\/profile_images\/904380437224497154\/N2YbNWOK_normal.jpg","description":"A former stroke neurologist. Looking for that something that will bring the everlasting peace of mind. Tern Surge Ltd + Merida Reacto 4000 + Subaru S207","id_on_source":"deep_wreck","tweeter_id":"155049140","geo":{"lt":null,"ln":null},"followers":753},"tweet_id":"725807784743161856"},{"url":"http:\/\/twitter.com\/L2583\/statuses\/726496274468470784","license":"gnip","rt":["NeurologyToday"],"citation_ids":[6985628],"posted_on":"2016-04-30T19:39:44+00:00","author":{"name":"L2583","url":"http:\/\/www.pamperyourselfdaily.com","image":"https:\/\/pbs.twimg.com\/profile_images\/649607263234060289\/qNJv6ISD_normal.jpg","description":"Health researcher & Prof. Passionate about health,wellbeing,living a balanced life in body, mind & spirit. Self-responsibility,self-care & living well each day.","id_on_source":"L2583","tweeter_id":"335297041","geo":{"lt":null,"ln":null},"followers":251},"tweet_id":"726496274468470784"},{"url":"http:\/\/twitter.com\/lgeneral15\/statuses\/726504327582507008","license":"gnip","rt":["NeurologyToday"],"citation_ids":[6985628],"posted_on":"2016-04-30T20:11:44+00:00","author":{"name":"Alicia","url":"http:\/\/pamperyourselfdaily.com","image":"https:\/\/pbs.twimg.com\/profile_images\/648929628875153408\/BVo6V4B6_normal.jpg","id_on_source":"lgeneral15","tweeter_id":"430624899","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":245},"tweet_id":"726504327582507008"},{"url":"http:\/\/twitter.com\/C_OrejaGuevara\/statuses\/728913090243403776","license":"gnip","citation_ids":[6985628],"posted_on":"2016-05-07T11:43:17+00:00","author":{"name":"Celia Oreja-Guevara","image":"https:\/\/pbs.twimg.com\/profile_images\/3627623150\/73fe6f281ee92a7007c739ae965cee5c_normal.jpeg","description":"Jefe de Secci\u00f3n de Neurolog\u00eda. Multiple Sclerosis Expert. Neurologist, Neur\u00f3logo de Hospital Clinico San Carlos. Profesor Asociado de la Universidad Complutense","id_on_source":"C_OrejaGuevara","tweeter_id":"1221603110","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1152},"tweet_id":"728913090243403776"},{"url":"http:\/\/twitter.com\/mikel_franco\/statuses\/728913156572127232","license":"gnip","rt":["C_OrejaGuevara"],"citation_ids":[6985628],"posted_on":"2016-05-07T11:43:33+00:00","author":{"name":"Mikel Franco","url":"http:\/\/linkedin.com\/in\/mikel-franco-83039a69","image":"https:\/\/pbs.twimg.com\/profile_images\/627166501842329600\/-BmYYdJi_normal.jpg","description":"#TrabajoenNovartis - Tweets Basados en mi Opini\u00f3n Personal - Apasionado del Social Media, Coach y hacer felices a los dem\u00e1s","id_on_source":"mikel_franco","tweeter_id":"374403210","geo":{"lt":43.26271,"ln":-2.92528,"country":"ES"},"followers":555},"tweet_id":"728913156572127232"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/758957795739742208","license":"gnip","citation_ids":[6985628],"posted_on":"2016-07-29T09:30:13+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"758957795739742208"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/764378494495141888","license":"gnip","citation_ids":[6985628],"posted_on":"2016-08-13T08:30:09+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"764378494495141888"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/765103265973272576","license":"gnip","citation_ids":[6985628],"posted_on":"2016-08-15T08:30:08+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"765103265973272576"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/767655087942410240","license":"gnip","citation_ids":[6985628],"posted_on":"2016-08-22T09:30:09+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"767655087942410240"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/769486149739909120","license":"gnip","citation_ids":[6985628],"posted_on":"2016-08-27T10:46:09+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"769486149739909120"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/770210919687139328","license":"gnip","citation_ids":[6985628],"posted_on":"2016-08-29T10:46:07+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"770210919687139328"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/771399774335401984","license":"gnip","citation_ids":[6985628],"posted_on":"2016-09-01T17:30:12+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"771399774335401984"},{"url":"http:\/\/twitter.com\/MSMmeeting\/statuses\/771762204773265408","license":"gnip","citation_ids":[6985628],"posted_on":"2016-09-02T17:30:22+00:00","author":{"name":"MS Management","url":"https:\/\/www.multiplesclerosismanagement.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/699176937579741184\/GYGxN_-v_normal.png","description":"Channel to HCP interested in #MultipleSclerosis. Broadcast of the MS Management meeting #MSM16, Vienna, March 11th-12th, 2016. Supported by Teva Neuroscience","id_on_source":"MSMmeeting","tweeter_id":"4806099981","geo":{"lt":48.33333,"ln":15.75,"country":"AT"},"followers":405},"tweet_id":"771762204773265408"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/774661265327173632","license":"gnip","citation_ids":[6985628],"posted_on":"2016-09-10T17:30:12+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"774661265327173632"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/776473189752803328","license":"gnip","citation_ids":[6985628],"posted_on":"2016-09-15T17:30:09+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"776473189752803328"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/778889110370996224","license":"gnip","citation_ids":[6985628],"posted_on":"2016-09-22T09:30:09+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"778889110370996224"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/778908240792870912","license":"gnip","citation_ids":[6985628],"posted_on":"2016-09-22T10:46:10+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"778908240792870912"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/780720170310340608","license":"gnip","citation_ids":[6985628],"posted_on":"2016-09-27T10:46:08+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"780720170310340608"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/781410769560674304","license":"gnip","citation_ids":[6985628],"posted_on":"2016-09-29T08:30:20+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"781410769560674304"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/782860293281951744","license":"gnip","citation_ids":[6985628],"posted_on":"2016-10-03T08:30:13+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"782860293281951744"},{"url":"http:\/\/twitter.com\/POSTECTRIMS\/statuses\/783962561754431488","license":"gnip","citation_ids":[6985628],"posted_on":"2016-10-06T09:30:14+00:00","author":{"name":"POSTECTRIMS","url":"http:\/\/9nl.cc\/iiyn","image":"https:\/\/pbs.twimg.com\/profile_images\/724904040946106368\/IydOgBk4_normal.jpg","description":"Canal para sanitarios interesados en #EsclerosisMultiple. Retransmisi\u00f3n X Reuni\u00f3n #postEctrims 10-11 Nov 17 #ectrims Farmacovigilancia: http:\/\/xs.gy\/7evr","id_on_source":"POSTECTRIMS","tweeter_id":"379971177","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1401},"tweet_id":"783962561754431488"}],"facebook":[{"url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10154993513045712&id=193133835711","license":"public","citation_ids":[15402482,6985628],"posted_on":"2017-01-13T19:36:17+00:00","summary":"The rates of retinal layer atrophy varied among patients with relapsing-remitting multiple sclerosis by the type of disease-modifying therapy used, according to a study published online January 11 in Neurology. Given the accessibility of retinal tissue, th","author":{"name":"Neurology Today","url":"https:\/\/www.facebook.com\/193133835711","facebook_wall_name":"Neurology Today","image":"https:\/\/graph.facebook.com\/193133835711\/picture","id_on_source":"193133835711"}},{"title":"News from the AAN Annual Meeting: Retinal Thickness Predicts... :...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10154203395095712&id=193133835711","license":"public","citation_ids":[6985628],"posted_on":"2016-04-27T12:01:21+00:00","summary":"A large longitudinal cohort study found that retinal thickness could be an independent predictor of disease progression for people with multiple sclerosis. A test for measuring retinal thickness, optical coherence tomography (OCT), would be helpful to incl","author":{"name":"Neurology Today","url":"https:\/\/www.facebook.com\/193133835711","facebook_wall_name":"Neurology Today","image":"https:\/\/graph.facebook.com\/193133835711\/picture","id_on_source":"193133835711"}}]}}